The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 08, 2025

Filed:

Apr. 25, 2022
Applicant:

Rani Therapeutics, Llc, San Jose, CA (US);

Inventor:

Mir Imran, Los Altos Hills, CA (US);

Assignee:

Rani Therapeutics, LLC, San Jose, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 31/00 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 31/155 (2006.01); A61K 38/17 (2006.01); A61K 38/22 (2006.01); A61K 38/26 (2006.01); A61K 38/27 (2006.01); A61K 38/28 (2006.01); A61K 38/29 (2006.01); A61K 45/06 (2006.01); A61M 5/14 (2006.01); A61M 5/142 (2006.01); A61M 5/168 (2006.01); A61M 5/172 (2006.01); A61M 5/20 (2006.01);
U.S. Cl.
CPC ...
A61M 31/002 (2013.01); A61K 9/0065 (2013.01); A61K 9/48 (2013.01); A61K 9/4808 (2013.01); A61K 31/155 (2013.01); A61K 38/17 (2013.01); A61K 38/22 (2013.01); A61K 38/2235 (2013.01); A61K 38/26 (2013.01); A61K 38/27 (2013.01); A61K 38/28 (2013.01); A61K 38/29 (2013.01); A61K 45/06 (2013.01); A61M 5/168 (2013.01); A61M 5/1723 (2013.01); A61M 5/20 (2013.01); A61M 2005/1401 (2013.01); A61M 5/14276 (2013.01); A61M 2005/14284 (2013.01); A61M 2210/106 (2013.01); A61M 2230/005 (2013.01);
Abstract

Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Some embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. The device comprises a capsule sized to be swallowed and pass through the intestinal tract. The capsule can include at least one guide tube, one or more tissue penetrating members positioned in the guide tube, a delivery member, an actuating mechanism and a release element. The release element degrades upon exposure to various conditions in the intestine so as to release and actuate the actuating mechanism. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.


Find Patent Forward Citations

Loading…